(Q34560858)

3 August 2017

Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study (English)

1 reference

generalized anxiety disorder

3 August 2017

1 reference

2

1 reference

3 August 2017

Gianna Sepede

5

0 references

author name string

Francesco Gambi

1

1 reference

3 August 2017

Daniela Campanella

3

1 reference

3 August 2017

Alessandro Carano

4

1 reference

3 August 2017

Gabriele Salini

6

1 reference

3 August 2017

Daniela Mezzano

7

1 reference

3 August 2017

Alessandra Cicconetti

8

1 reference

3 August 2017

Laura Penna

9

1 reference

3 August 2017

Rosa Maria Salerno

10

1 reference

3 August 2017

Filippo Maria Ferro

11

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Journal of Psychopharmacology

3 August 2017

1 reference

3 August 2017

19

1 reference

3 August 2017

483-487

1 reference

3 August 2017

5

1 reference

Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial

3 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Mirtazapine in major depression with comorbid generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Mirtazapine versus fluoxetine in the treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Mirtazapine in the treatment of panic disorder: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Irritability: definition, assessment and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

Mirtazapine in social anxiety disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056527

21 January 2018

Identifiers

DOI

10.1177/0269881105056527

1 reference

release_m34skabh3jet5pbon6ovhyc5xi

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m34skabh3jet5pbon6ovhyc5xi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference